SEC Form 4 · accession 0001209191-16-117771
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christian S Schade
Director
Period of report
May 3, 2016
Accepted (ET)
May 5, 2016 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 3, 2016 | M | 7,829 | $41.21 | A | 18,550 | D | |
| Common StockF2,F1 | May 3, 2016 | S | 7,829 | $70.4191 | D | 10,721 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4,F3 | $41.21 | May 3, 2016 | M | 7,829 | D | — | Aug 19, 2016 | Common Stock | 7,829 | 0 | D |
Explanation of responses
- F1Includes 358 shares of common stock issued as restricted stock pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.
- F2The price shown above represents the weighted average price of the shares sold. The range of sale prices was $70.30 to $70.57.
- F325% of the stock options vest every quarter from the grant date of 8/19/2008.
- F4This option was previously reported as covering 7,500 shares at an exercise price of $47.63 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.